| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
257,554 |
225,595 |
$38.04M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
220,366 |
192,523 |
$1.94M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
111,088 |
98,574 |
$1.47M |
| 59425 |
|
5,522 |
3,520 |
$415K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12,357 |
12,308 |
$361K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,133 |
6,089 |
$323K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
8,814 |
8,802 |
$312K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,093 |
5,077 |
$261K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,898 |
2,886 |
$250K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,956 |
6,917 |
$248K |
| 97802 |
|
3,291 |
3,266 |
$198K |
| 99215 |
Prolong outpt/office vis |
2,431 |
2,381 |
$195K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,667 |
7,582 |
$192K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
8,554 |
7,314 |
$182K |
| 90686 |
|
17,182 |
17,149 |
$171K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
1,689 |
1,684 |
$150K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,745 |
5,662 |
$143K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,006 |
1,999 |
$135K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,551 |
2,533 |
$135K |
| 90750 |
|
824 |
821 |
$130K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,411 |
4,709 |
$122K |
| 99406 |
|
12,794 |
11,286 |
$114K |
| 90715 |
|
4,088 |
4,075 |
$113K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
745 |
389 |
$111K |
| 99174 |
|
2,809 |
2,799 |
$103K |
| 92250 |
|
2,042 |
2,031 |
$97K |
| 92551 |
|
19,243 |
19,175 |
$97K |
| 97803 |
|
2,652 |
2,513 |
$92K |
| 90670 |
|
5,936 |
5,892 |
$79K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
10,094 |
9,950 |
$76K |
| 99188 |
|
3,734 |
3,725 |
$66K |
| 0002A |
|
1,142 |
604 |
$60K |
| 90651 |
|
3,060 |
3,056 |
$57K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,037 |
8,866 |
$55K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
9,073 |
8,542 |
$54K |
| H1003 |
Prenatal care, at-risk enhanced service; education |
2,109 |
1,694 |
$53K |
| 71046 |
Radiologic examination, chest; 2 views |
2,086 |
2,065 |
$46K |
| 95886 |
|
752 |
375 |
$46K |
| 0001A |
|
857 |
452 |
$45K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,397 |
5,085 |
$43K |
| J3490 |
Unclassified drugs |
1,736 |
1,724 |
$43K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
17,873 |
14,302 |
$40K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,597 |
2,552 |
$37K |
| 90633 |
|
4,309 |
4,281 |
$32K |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
383 |
254 |
$31K |
| 17110 |
|
274 |
236 |
$31K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,567 |
2,522 |
$29K |
| 90647 |
|
4,281 |
4,250 |
$29K |
| 0072A |
|
531 |
311 |
$28K |
| 90723 |
|
4,200 |
4,148 |
$28K |
| 0064A |
|
538 |
380 |
$28K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,148 |
1,143 |
$27K |
| 90716 |
|
1,896 |
1,880 |
$27K |
| 0071A |
|
503 |
331 |
$26K |
| 90734 |
|
2,117 |
2,111 |
$25K |
| 0969 |
|
371 |
220 |
$25K |
| 90707 |
|
1,782 |
1,766 |
$24K |
| 90837 |
Psychotherapy, 53 minutes with patient |
926 |
440 |
$22K |
| 99243 |
|
323 |
323 |
$22K |
| 82274 |
|
1,177 |
1,168 |
$20K |
| G9920 |
Screening performed and negative |
7,960 |
7,938 |
$20K |
| 90710 |
|
1,619 |
1,616 |
$20K |
| 81025 |
|
6,296 |
6,149 |
$19K |
| 90680 |
|
2,393 |
2,357 |
$19K |
| 0004A |
|
339 |
195 |
$18K |
| 90677 |
|
863 |
860 |
$17K |
| 81002 |
|
16,736 |
15,717 |
$17K |
| 90700 |
|
1,711 |
1,697 |
$16K |
| 73562 |
|
711 |
690 |
$15K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
83 |
83 |
$15K |
| 90696 |
|
1,454 |
1,451 |
$14K |
| 73030 |
|
553 |
501 |
$12K |
| 99385 |
|
127 |
127 |
$12K |
| 99245 |
|
93 |
92 |
$12K |
| 90662 |
|
523 |
523 |
$11K |
| 59430 |
|
138 |
136 |
$11K |
| 73630 |
|
523 |
504 |
$11K |
| 72100 |
|
405 |
405 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
734 |
702 |
$10K |
| 90688 |
|
622 |
619 |
$7K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,006 |
923 |
$6K |
| 90681 |
|
991 |
987 |
$6K |
| 0012A |
|
112 |
60 |
$6K |
| 99173 |
|
9,078 |
9,064 |
$6K |
| 96127 |
|
1,286 |
1,234 |
$5K |
| 90682 |
|
75 |
75 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
368 |
367 |
$4K |
| 0003A |
|
67 |
37 |
$4K |
| 90697 |
|
534 |
532 |
$3K |
| 86580 |
|
710 |
697 |
$3K |
| 90685 |
|
264 |
264 |
$3K |
| 0011A |
|
49 |
27 |
$3K |
| 99386 |
|
16 |
16 |
$3K |
| 99241 |
|
55 |
55 |
$2K |
| 99205 |
Prolong outpt/office vis |
17 |
17 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
78 |
27 |
$2K |
| 0761 |
|
62 |
61 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
38 |
15 |
$2K |
| 93226 |
|
24 |
24 |
$2K |
| 73610 |
|
79 |
77 |
$2K |
| 72110 |
|
49 |
49 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
240 |
234 |
$1K |
| G9919 |
Screening performed and positive and provision of recommendations |
132 |
131 |
$1K |
| 82948 |
|
703 |
668 |
$1K |
| 0054A |
|
17 |
17 |
$1K |
| 90746 |
|
26 |
26 |
$1K |
| 96156 |
|
38 |
34 |
$1K |
| 90674 |
|
109 |
109 |
$1K |
| 99384 |
|
27 |
27 |
$1K |
| 20610 |
|
25 |
24 |
$966.21 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$900.51 |
| 69209 |
|
63 |
57 |
$795.10 |
| G0071 |
Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only |
140 |
129 |
$788.78 |
| 59025 |
Fetal non-stress test |
27 |
14 |
$777.48 |
| 99401 |
|
123 |
121 |
$755.58 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
117 |
84 |
$746.39 |
| 90834 |
Psychotherapy, 45 minutes with patient |
15 |
12 |
$740.55 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
21 |
21 |
$603.54 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
28 |
27 |
$571.00 |
| 73502 |
|
14 |
12 |
$471.82 |
| H0049 |
Alcohol and/or drug screening |
14 |
14 |
$416.40 |
| 93227 |
|
13 |
12 |
$405.05 |
| 73620 |
|
28 |
26 |
$369.20 |
| 73560 |
|
25 |
25 |
$347.29 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
44 |
43 |
$326.52 |
| 94664 |
|
32 |
31 |
$309.79 |
| D1206 |
Topical application of fluoride varnish |
13 |
13 |
$302.40 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
37 |
26 |
$298.78 |
| 90671 |
|
32 |
32 |
$288.00 |
| 69210 |
|
79 |
71 |
$284.68 |
| 77077 |
|
12 |
12 |
$276.97 |
| 73110 |
|
13 |
12 |
$262.98 |
| 72040 |
|
12 |
12 |
$257.64 |
| 90713 |
|
26 |
26 |
$245.09 |
| A4649 |
Surgical supply; miscellaneous |
104 |
104 |
$165.83 |
| 90744 |
|
14 |
14 |
$154.63 |
| 85018 |
|
55 |
55 |
$132.85 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
203 |
200 |
$84.30 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
15 |
14 |
$2.50 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
13 |
12 |
$0.30 |
| Z1034 |
|
3,766 |
2,755 |
$0.00 |
| 90656 |
|
413 |
412 |
$0.00 |
| Z6410 |
|
188 |
119 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
31 |
31 |
$0.00 |
| 90480 |
|
12 |
12 |
$0.00 |
| 0636 |
|
17 |
16 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$0.00 |
| Z1032 |
|
12 |
12 |
$0.00 |
| Z6400 |
|
745 |
717 |
$0.00 |
| 91322 |
|
13 |
13 |
$0.00 |